Last reviewed · How we verify

NCT05263765

Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery

Status unknown Last updated 28 March 2024
What this trial tests

trial testing utilization of AO in the acute resuscitation of trauma and acute care surgery patients in shock. in Aortic Occlusion in 100 participants. Status unknown.

Timeline
29 December 2022
Primary endpoint
29 December 2024
29 December 2024

Quick facts

Lead sponsorMethodist Health System
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date29 December 2022
Primary completion29 December 2024
Estimated completion29 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Methodist Health System — full company profile →

Who can join

Adults 18 to 100, any sex, with Aortic Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aortic occlusion (AO) for trauma has traditionally been accomplished by supra-diaphragmatic clamping of the descending thoracic aorta via emergent thoracotomy or as an initial step during laparotomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Methodist Health System trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05263765.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing